Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension

BACKGROUND: Flolan (epoprostenol sodium) is most commonly prescribed to patients with severe pulmonary arterial hypertension (PAH) owing to the requirement that the drug be delivered by continuous intravenous infusion and the reconstituted solution may only be administered up to 24 hours when it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Provencher, Steeve, Paruchuru, Patrap, Spezzi, Andrea, Waterhouse, Brian, Gomberg-Maitland, Mardi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368561/
https://www.ncbi.nlm.nih.gov/pubmed/25793960
http://dx.doi.org/10.1371/journal.pone.0120657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368561/
https://www.ncbi.nlm.nih.gov/pubmed/25793960
http://dx.doi.org/10.1371/journal.pone.0120657

Ejemplares similares